Our Accomplishments | SingHealth Duke-NUS

Notable Trials Conducted in IMU:

LUNAR COVID-19 Vaccine Trial (Phase I)

The SingHealth Investigational Medicine Unit is administering the trial for the vaccine.

Source: https://www.healthxchange.sg/news/early-stage-coronavirus-vaccine-trial-begins-in-singapore

Source: https://www.todayonline.com/singapore/singapore-arcturus-covid-19-vaccine-seeks-100-healthy-adult-volunteers-next-trial-phase

Clinical Trials for Potential COVID-19 Treatment

The phase one trial, developed by Singapore based biotechnology company Tycan, will be conducted by the SingHealth Investigational Medicine Unit and take about six weeks.

Source: https://www.healthxchange.sg/news/singapore-based-firm-to-start-human-trials-for-potential-coronavirus-drug

BABE Haematology

• Had the largest cohort of subjects recruited at one session (24 subjects)

• 9 overnight stays in total with 7 outpatient visits in between (total 16 consecutive days)

FIM Dose Escalation Trial

• Randomised double blind chemo drug

• 2 fasted dosing periods & 1 fed period (each period had 4 overnight stays + 1 outpatient visit)

• Skin biopsy and hair follicle collection

BABE Hypertension

• Recruited 12 Caucasian subjects